Figure 6.

Management of ICI-associated myocarditis at Vanderbilt University Medical Center. Depicted is the screening and surveillance algorithm used at Vanderbilt for patients with increased risk of developing ICI-associated myocarditis, namely, patients on combination immunotherapy. ATG, anti-thymocyte globulin; CCU, coronary care unit; CHF, congestive heart failure; CK, creatine kinase; CK-MB, creatine kinase-muscle/brain; cMRI, cardiac magnetic resonance imaging; EKG, electrocardiogram; ICI, immune checkpoint inhibitor; IV, intravenous; MI, myocardial infarction. Icons from Servier Medical Art and the Noun Project are shared under a Creative Commons Attribution 3.0 Unported License.